about
Acelyrin Inc is a late-stage clinical biopharmaceutical company. The clinical biopharma segment researches and develops treatments for diseases with pathology related to excess activation of the immune system. It is focused on providing patients with...
Read More
4.1M
XNAS Volume
High volume today
XNAS 20 May, 2025 5:30 PM (EDT)
Not Eligible
Expensive Valuation
Technically Bearish
Acelyrin Inc Live Price Chart
Switch to TradingView
Loading Fundamental data..
Loading data..